<unk> , sold under the brand name Eucreas among others, is a fixed-dose combination anti-diabetic medication for the treatment of type 2 diabetes. It was approved for use in the European Union in November 2007, and the approval was updated in 2008. It combines 50 mg<unk>  with either 500, 850, or 1000 mg metformin. The most common side effects include nausea (feeling sick), vomiting, diarrhea, abdominal (tummy) pain and loss of appetite.
Vildagliptin/metformin
Glibenclamide/metformin
Pioglitazone/metformin
Sitagliptin/metformin
Insulin degludec/liraglutide
Canagliflozin/metformin
Empagliflozin/metformin
Dapagliflozin/saxagliptin/metformin